Microfluidic production of synthetic cyclic peptides
Researchers from the CITOS Laboratory contribute to the development of a new production method of cyclic peptides in the pharmaceutical field.
As a public university open to the world and is anchored in the scientific, cultural and economic development of its region, the University of Liège relies on its three pillars: teaching, research and civic engagement.
ULiège trains responsible citizens who are provided with cutting-edge knowledge and critical thinking, are able to share knowledge and can push forward an increasingly complex world.
ULiège develops and promotes excellence in research, multidisciplinary and direct engagement with its instruction.
Global exposure is a top priority at the University of Liège. The institution offers a wide range of international mobility opportunities to students, researchers and staff, enabling them to enhance their cross-disciplinary skills and language knowledge.
ULiège: an experience of daily living. Located in 3 cities and 4 campuses, the university is a key player in terms of the environment and mobility.
Researchers from the CITOS Laboratory contribute to the development of a new production method of cyclic peptides in the pharmaceutical field.
GIGA researcher Thomas Marichal is awarded a €1.5 million European grant to finance his IM-ID project.
Two publications in which researchers from the LPAP (STAR Institute) have taken part shed a little more light on Jupiter's auroras.
Researchers at ULiège have just developed a new process for manufacturing quantum Josephson junctions connecting two superconducting banks through a nanoscale link.
Parmi les 331 bourses octroyées par le FRS-FNRS cette année, 88 financeront des recherches menées par des chercheurs de l'ULiège.
During his visit, the Minister has discovered certain facilities but also learned about the economic impact of the research conducted at CIRM.
This prize rewards his work in the field of multidimensional separation sciences in analytical chemistry.
Thanks to this discovey published in Arthritis Research and Therapy, patients could soon be diagnosed with early-stage arthritis and have risk of developing increased severity of symptoms and response to new treatments assessed by measurement of a new blood-based marker - glucosepane.
Créez une oeuvre traitant du cerveau et aidez au financement d’un projet pour patients souffrant d’une maladie cérébrale.
A team of researchers led by Dr Pierre Close, WELBIO investigator of the GIGA Institute from ULIEGE and Dr Francesca Rapino (ULIEGE) has uncovered a novel therapeutic opportunity in the treatment of melanoma that acquired resistance to targeted therapies.
Researchers from the Université libre de Bruxelles and the University of Liège mark a breakthrough in understanding the interaction between immune cells and cancer cells, via the deregulation of the epigenetic machinery.
The data, collected by the space probe in orbit around the Red Planet over the past 4 years, have made it possible to quantify a rate of erosion that is constantly changing.